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ABSTRACT 
Patients under palliative care commonly experience a multitude of conditions that 
contribute to the development of chronic pain and depression. These patients are also commonly 
prescribed opioid analgesic medications to promote palliation and comfort. Higher rates of 
underlying depression among patients with chronic pain has been shown to increase risks for 
self-medicating and inappropriate use of prescribed opioids. Inappropriate use of opioids poses 
serious concerns for patients’ health, and also presents a significant burden on the US healthcare 
system. Mindfulness-based cognitive therapy (MBCT) has been demonstrated to be a potentially 
useful non-pharmacological method for addressing depressive symptoms without common side 
effects seen in traditional antidepressant therapy. The purpose for this project was to educate 
palliative care staff members, including providers, nurses and social workers, concerning the 
benefits of using MBCT for addressing depression among patients with chronic pain, while also 
potentially improving upon patients’ adherence to taking opioids as prescribed. A pretest survey 
was distributed to participants to gain insight into their beliefs and understanding concerning the 
use of MBCT in the treatment of depression. Following the completion of the pretest, an 
educational webinar was distributed to participants which was then be followed by a posttest 
survey containing the same questions as the pretest survey. All participation was voluntary, and 
the identity of all participants will remain anonymous to promote confidentiality throughout the 
project. There were a total of 25 participants for this project with six unique pretest/posttest 
responses collected and analyzed accordingly which showed significant improvement in each 
category which thus supports the merit of educating palliative care staff regarding the use of 
MBCT for patients which chronic pain and depression who are under palliative care. 
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INTRODUCTION 
To address underlying depression, the Centers for Disease Control and Prevention (CDC) 
has recommended the use of adjunct therapies in their updated opioid guidelines, which includes 
the use of non-pharmacological therapies that have demonstrated efficacy in treating both 
underlying chronic pain, as well as limiting psychological contributors to pain, including 
depression (CDC, 2016). Recently, former Surgeon General, Dr. Vivek Murthy, echoed these 
sentiments and emphasized the need for educating healthcare providers on the availability and 
benefits of using alternative treatments to opioid-based therapies (Murthy, 2016). One such 
alternative therapy for addressing chronic pain is mindfulness-based cognitive therapy (MBCT), 
which has been shown to be helpful for treating depression which is commonly seen among 
patients suffering from chronic pain. MBCT is unique form of cognitive-behavioral therapy that 
uses meditative practices that emphasizes minimizing negative thoughts as a means to increase 
the participant’s mindfulness which can translate into improvements in psychological and 
physical wellbeing (Parsons, Crane, Parsons, Fjorback, & Kuyken, 2017). While traditionally 
performed in a classroom milieu, MBCT has also been adapted for use in home-based settings 
with prerecorded sessions that can be accessed at the convenience of the participant (Parsons, 
Crane, Parsons, Fjorback, & Kuyken, 2017). This project will focus on educating healthcare 
professionals about the benefits of using MBCT as a viable complementary therapy for palliative 
care patients with chronic pain who have underlying depression.  
Background and Significance 
Management of chronic pain, as defined as recurrent or persistent pain lasting at least 12 
weeks, poses a number of significant challenges for palliative care staff (Healthline, 2017). To 
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begin illustrating these concerns, it is important for staff to understand that etiological sources 
for chronic pain may include acute trauma, chronic disease processes, malignancies, infections, 
surgical complications or even psychogenic origins (Healthline, 2017). This then may translate 
into some forms of chronic pain being nociceptive pain (which includes somatic and visceral 
pain) neuropathic pain (for example diabetic neuropathy), pain with no clear pathway (such as 
non-specific lower back pain) or a combination of differing types of underlying pain. 
Furthermore, previously enacted protocols to alleviate chronic pain resulted in the 
overprescribing of opioid analgesics which have shown limited efficacy while posing severe 
consequences for patients. Between 2000 and 2016 prescribing of opioids increased fourfold and 
of the resulting 600,000 drug-related fatalities during this respective timeframe, roughly two-
thirds involved an opioid (CDC, 2017). The rise in prescription opioids ironically has not 
resulted in improvements in overall pain reported by Americans (CDC, 2017).  
Another concerning aspect related to chronic pain treatment lies in the associated costs, 
which includes lost productivity and healthcare-related needs, that has been estimated in the 
United States to amount to between $560 to $635 billion dollars (Gaskin, 2012). This staggering 
figure makes the economic burden associated with treating chronic pain more costly than that of 
treating heart disease, diabetes or cancer (Gaskin, 2012). Chronic pain is also a commonly 
encountered medical condition in America. It is believed that over 25 million Americans suffer 
from some form of chronic pain, and individuals with chronic pain have consistently 
demonstrated poor health statuses when compared to individuals without chronic pain (National 
Institutes of Health, 2015).  
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In addition to the risks that opioids pose for patients with chronic pain, depression is a 
common comorbidity that poses serious risks to patients’ phychological and physical health, and 
this will be the focal point for this proposal. For the purpose of this paper, depression will be 
used interchangeably with major depressive disorder (MDD) as defined as having persistent 
correlated signs and symptoms lasting at least two weeks such as sadness, emptiness, 
hopelessness, pessimism, fatigue, lack of energy, sleep disturbances, physical ailments such as 
aches and pains with no physical cause, impaired decision making and or loss of interest or 
pleasure in activities previously found to be engaging or pleasurable (National Institute of 
Mental Health, 2018).  
Evidence to Support MBCT for Depression Treatment 
In a recent meta-analysis of 115 unique randomized controlled trials (RCTs), which 
included a total of 8,683 participants that utilized either MBCT or mindfulness-based stress 
reduction therapies versus treatment as usual, MCBT was consistently demonstrated to 
statistically improve depressive symptoms in patients with chronic pain (Gotnik et al., 2015). In 
a similar fashion, a meta-analysis with systematic review conducted by Hilton et al. (2017) was 
comprised of 38 different RCTs, with study sizes ranging between 19 to 342 individuals, focused 
on the efficacy of mindfulness meditation in patients with chronic pain for pain control and 
depressive symptoms. This comprehensive review concluded that mindfulness meditation 
demonstrated a small improvement in overall pain control but more importantly, a statistically 
significant improvement in depression symptoms which translates into improved quality of life 
for paitents with chronic pain and depression (Hilton et al., 2017). Additionally, patients who 
have a dual diagnosis of depression and chronic pain who underwent MBCT reported a decrease 
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in depression symptoms and which coincided with a decrease in perceived pain burden (Gotnik 
et al., 2015). This paper will demonstrate the need to educate healthcare professionals regarding 
MBCT, which can serve as a means of feasibly and effectively addressing underlying depression 
in patients with a concurrent diagnosis of chronic pain. Furthermore, research has shown that 
depression is a risk factor for abusing and or misusing opioids and, therefore, managing 
depression may lead to reducing the risk for overreliance on opioid analgesic therapies and 
improving patients’ safety in the process (Grattan, Sullivan, Saunders, Campbell, & Von Korff, 
2012).  
Depression Statistics and Treatment Considerations 
Palliative care involves the alleviation of suffering with a strong emphasis of improving 
the quality of life for patients versus curative measures. Patients receiving palliative care have a 
myriad of life-limiting diseases which increases vulnerability to depression and chronic pain. 
MDD continues to be one of the most commonly encountered mental health diseases and carries 
the highest measure of disability among sufferers when compared to the entirety of mental health 
disorders (National Institute of Mental Health, 2016). The likelihood of suffering from 
depression goes up substantially when chronic pain is involved. While difficult to accurately 
quantify, current medical literature estimates that MDD among patients with chronic pain may be 
anywhere from 18% in less severe cases of chronic pain to as high as 85% in patients being seen 
at specialized pain treatment centers (Jong et al., 2017). Traditional therapies for depression 
often involve the use of psychotropic medications including, selective serotonin reuptake 
inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), norepinephrine 
reuptake inhibitors (NRIs), tricyclic antidepressants (TCAs) and to a lesser extent, monoamine 
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oxidase inhibitors (MAOIs). However, significant drawbacks can accompany these traditional 
therapies including weight gain, sexual dysfunctions, nausea, dry mouth, urinary retention, 
blurred vision, constipation, relatively long therapeutic onset times and in some cases, costs are 
also a concern (Santarsieri & Schwartz, 2015). Collectively this can lead to significant 
compromises in patients’ quality of life and which contributes to relatively high discontinuation 
rates which have been estimated to vary between 16% to 33% depending on the specific 
treatment and ages of individuals involved (Santarsieri & Schwartz, 2015).  
MBCT has advantages of being cost-effective and successful for treating depression 
without the underlying concerns that typical antidepressant therapies possess. A recent research 
study found that MBCT was just as efficacious as Zoloft in minimizing relapses of MDD when 
used as a first line therapy for depression, with the added benefits of mitigating the severity of 
depressive symptoms and also supporting self-care coping techniques to assist patients in 
managing their depression (Eisendrath et al., 2015). Another study involving a RCT compared 
routine antidepressant therapy versus MBCT and found similar results between both approaches 
in terms of preventing depression relapses (Kuyken et al., 2015). In terms of quantifying 
benefits, MBCT has been found to reduce the severity of depressive symptoms by 65-67% in 
patients with MDD who were identified as at a high risk for relapses in depressive episodes 
(Lilja, Zelleroth, Axberg, & Norlander, 2016). Given the fact that patients on palliative care have 
serious and life-limiting diseases, MBCT should be considered as an adjunct therapy for 
addressing depression in patients with chronic pain given the effectiveness at managing 
depressive symptoms without posing concerns that traditional pharmacological approaches to 
care may present.  
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Needs Assessment 
The promotion of a safe and effective means for alleviating underlying depressive 
symptoms in patients who have chronic pain is imperative. To better put this into perspective, a 
needs assessment of the project implementation site was conducted to clearly identify current 
limitations in this healthcare practice and to demonstrate evidence-based literature to support the 
need for addressing depression among their patients with chronic pain who are under palliative 
care. The identification of concerns are as follows: 
 Depression screening protocols for palliative care patients with chronic pain does not 
exist despite research findings supporting depression screening in this population. 
o Studies of patients on palliative care diagnosed with chronic pain show a 
significant association between perceived pain and psychiatric morbidity of 
underlying depression (Rajmohan & Kumar, 2013). 
o A recent study featuring patients who were receiving long-term opioid therapy 
showed that individuals with moderate to severe depression were 1.8 times and 
2.4 times more likely to abuse prescription opioids, versus patients without 
depression undergoing similar opioid therapies (Grattan, Sullivan, Saunders, 
Campbell, & Von Korff, 2012).  
o This same study demonstrated that patients with mild, moderate and severe 
depression specifically admitted to misusing opioids by self-increasing doses at 
rates of 1.9 times, 2.9 times and 3.1 times respectively (Grattan, Sullivan, 
Saunders, Campbell, & Von Korff, 2012). Even more alarming was the fact that 
all participants in this study had no past history of substance abuse or misuse.  
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 Palliative care patients are at higher risk for depression and often have chronic pain 
concerns which increases risks for opioid misuse and or abuse.  
o Patients under palliative care are especially at risk for painful medical procedures 
associated with their underlying diseases, and therefore, there are inherent risks 
associated with opioid use in this specific patient population. Furthermore, given 
the fact that a high percentage of patients receiving palliative care have 
underlying pathologies (such as arthritis, metastatic cancers, diabetes etc.) that 
can directly illicit chronic pain, this poses a clear risk for both depression and 
misuse and or abuse of prescribed opioids.  
o Depression rates for patients on palliative care with chronic pain are higher than 
patients who have chronic pain but are not on palliative care. Research has also 
found a strong correlation betweeen depression among patients with chronic pain, 
with estimates stating an approximate 55% occurrence that is likely underreported 
(Merlin, Childers, & Arnold, 2013).  
o Patients on palliative care with chronic pain show higher risks for having a co-
diagnosis of depression. In patients who have chronic pain and are on palliative 
care, the incidence of depression rises to an estimated 67% with this estimate 
again likely to be an underrepresentation of the true prevalence of depression 
among affected individuals (Rajmohan & Kumar, 2013). 
Specific Project Goals 
 Goals of the project given underlying risks of the problem as identified by the needs 
assessment are as follows:  
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o Educate palliative care staff, including clinicians, nurses and social workers about the 
clinical practice guideline (CPG) recommendations as outlined by the CDC to address 
chronic pain among palliative care populations. 
o Studies analyzing factors that lead to the uptake of non-pharmacological treatment 
options illustrated the benefits of mindfulness-based therapies in patients with 
chronic pain and highlighted that healthcare staff and provider education was a 
key component for incorporating alternative therapies into actual practice (Becker 
et al., 2017). 
o Highlight benefits of using MBCT to promote pain control and minimize risk for 
patients. Literature has found MBCT has the dual benefit of providing statistically 
significant improvements in depressive symptoms with the added benefit of 
reducing the burden of chronic pain perceived by patients who underwent MBCT 
(Hilton et al., 2017). Additionally, a recent meta-analysis showed that MBCT was 
effective at treating depression without significant side effects generally seen with 
pharmaceutical antidepressant therapies (Kuyken et al., 2016).  
o Inform staff that MBCT is both effective in and cost-effective in preventing 
depression relapses. MBCT has demonstrated similar efficacy to traditional 
antidepressant medication therapy while having decreased associated side effects 
and minimal associated costs with implementing such therapies (Kuyken et al., 
2015).  
o Elucidate upon research that informs that MBCT has been found to somewhat 
minimize chronic pain intensity while having significantly positive effects on 
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treating underlying depression present in patients with chronic pain. CBTs, which 
includes MBCT, were acknowledged by the CDC as having a positive impact on 
both addressing underlying chronic pain, as well as limiting psychological 
distress, including depression (CDC, 2016). 
o MBCT supports self-care patient participation in addressing chronic pain and has 
been found to improve physical limitations in a safe and effective manner. 
Cognitive-based therapies, to include MBCT, have the advantage of encouraging 
active patient participation in their plan of care and can contribute to sustained 
improvements in overall pain and improved physical functioning without apparent 
risks (CDC, 2016).  
o MBCT has been found to have similar effectiveness at managing depression when 
compared to traditional pharmacological antidepressant therapies without 
unwanted side effects. Traditional depression management, as outlined 
previously, may pose significant risks to patients’ quality of life as opposed to 
MBCT, that has been found to have similar effectiveness without the risks 
associated with pharmacological treatments used for depression (Kuyken et al., 
2015).  
Purpose, Aims and Rationale for Recommendations 
The purpose of this proposal is to inform palliative care team members about the benefits 
of using MBCT to reduce symptoms of depression in patients on palliative care who have a 
diagnosis of chronic pain. The aim of the study is to enhance palliative care staffs’ knowledge 
regarding the use of MBCT for treating depression in palliative care patients who have chronic 
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pain. Also given that there is a nationwide push to decrease opioid prescribing citing the safety 
concerns associated with this practice, it is logical to conclude that palliative care populations are 
at high risk for not following opioid treatments as they are written. Therefore, in addition to 
addressing opioid abuse and or misuse, another primary objective would be to improve upon 
patient adherence to taking opioids as prescribed and avoiding overuse. Enhancing education 
about the benefits of MBCT for managing depression symptoms would serve to reduce the risks 
for opioid misuse and or abuse in palliative care patients with chronic pain concerns.  
The proposed agency and setting for this proposal is a large non-for-profit organization 
that specializes in hospice and palliative care approaches for both pediatric and adult patient 
populations. Stakeholders integral to this effort would be clinicians, nursing staff, social workers, 
clinical managers, patients, patient family members and society. Nursing leaders who have 
experience in executing evidence-based quality improvement undertakings, could serve as 
champions and could assist with scrutinizing current policy regarding identifying and treating 
underlying depression and comparing these with the CDC’s CPG recommendations. To 
accomplish this task a performance gap analysis may be helpful in determining this degree of 
disparity while identify key areas needing to be addressed for the adoption of the CDC’s CPG 
(Graham, 2011). This information could then assist in a plan of action for educating palliative 
care professionals about the consideration of using MBCT as an adjunct therapy for the treatment 
of depression among palliative care patients. 
Theoretical Framework 
Modern healthcare agencies are complex and adaptive entities that must undergo constant 
evolution and restructuring necessary to maintain viability within the greater healthcare system. 
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This requires agencies to adopt practices and cultures that are conducive towards innovative and 
new initiatives that will drive optimal clinical outcomes. Lewin’s Change Theory illustrates this 
in a three-step fashion that outlines how new ideas materialize from beliefs into actual practice. 
The first step involves unfreezing which is highlighted by creating awareness that an actual 
problem exists and driving the understanding that current practices and beliefs need to change to 
rectify this problem (Wojciechowski, Pearsall, Murphy, & French, 2016). This has been 
accomplished by sharing research with the lead medical director that informs about the issue that 
patients with chronic pain have high rates of underlying depression, and more importantly, this 
level of depression may be more common among patients under palliative care which 
demonstrates the need for translating research into practice (Rajmohan & Kumar, 2013). 
The second step in Lewin’s model involves changing current processes and 
demonstrating how alternative practices will have beneficial outcomes. This will involve 
educating about the use of MBCT and discussing specific tangible benefits of reducing 
depressive symptoms. Furthermore, information regarding the cost-effectiveness of MBCT to 
implement with added advantages over traditional antidepressant pharmacological therapies in 
terms of therapeutic onset and lack of serious side effects will be discussed (Kuyken et al., 
2015). Additionally, patients with chronic pain who undergo MBCT will learn positive coping 
skills and self-care techniques that can help limit negative coping which can potentially manifest 
in patients overcoming barriers present for not following opioid medication regimens and limit 
misusing or abusing opioid prescriptions in the process. 
The last step involves refreezing that promotes the integration of the new change into 
practice, while simultaneously limiting regressive behaviors towards antiquated practices and 
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restraining further unwanted changes (Wojciechowski, Pearsall, Murphy, & French, 2016). This 
step would be accomplished should the agency use the information gained from the quality 
improvement initiative to enact the CDC’s CPG recommendations for addressing opioid abuse 
and misuse among all patient populations and this supports the use of cognitive behavioral 
therapies which include MBCT (CDC, 2016). 
Lewin’s change theory also outlines three distinct forces that must be taken into account, 
including driving forces, inhibiting forces and equilibrium (Petiprin, 2016). For this proposal, 
one driving force would include staff that understand the detriments associated with the current 
opioid crisis and who identify with the need for current palliative care practices to change to 
address this problem. Additional driving could also include potentially limiting rehospitalization 
of patients under palliative care for pain exacerbations as MBCT has been shown to reduce both 
depressive symptoms and the overall perceived pain burden in patients with depression and 
chronic pain (Hilton et al., 2017). Inhibiting forces could entail several components including 
time and efforts involved with implementing the use of MBCT for palliative care patients with 
chronic pain and depression, staff that may have doubts regarding the efficacy of MBCT for 
treating depression and potential lack of adherence of MBCT practices by patients. The last force 
of equilibrium is achieved when inhibiting and driving forces are in balance and keep each other 
in check.  
Quality Improvement Model Selection 
In order to impart meaningful quality improvement efforts based upon current evidenced-
based practice (EBP), it is important to use a model that will guide how to identify shortcomings 
with current practice for a given healthcare setting, formulate a plan for bridging the gaps 
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between current practice and utilize EBP identified as beneficial for improving on existing 
processes. This writer contends that in order to address depression among patients on palliative 
care who have a concurrent diagnosis of chronic pain, providing education regarding this 
concern with be key. The hope is that utilizing MBCT can safely and effectively manage 
underlying depression which will reduce the overreliance on opioid analgesics and thus decrease 
opioid abuse and misuse among this population. To implement this change in clinical practice, 
the Advancing Clinical Practice through close Collaboration (ARCC) model will be used as the 
framework that will serve to identify potential barriers to the change, as well as lay the 
foundation for the implementation process. The ARCC model has been found to be highly 
effective at improving organizational culture and staff beliefs regarding the merits of EBP while 
also fostering the adoption of EBP recommendations via an organized systematic process 
(Melnyk, Fineout-Overholt, Giggleman, & Choy, 2017). 
The starting point in the ARCC model is to first identify and clearly define the problem. 
This has been accomplished through correspondence with the medical director of the target site 
regarding pain management modalities, showing that MBCT is not being utilized to address 
depression in palliative care patients with chronic pain. After the specific problem has been 
defined, it is imperative to assess the feasibility of implementing the change, as well as 
identifying potential barriers and inhibiting forces to implementing the change. This can include 
lack of sufficient EBP beliefs, inadequate facilitators to initiate the project and lack of 
involvement from potential participants. Conversely, elucidating on the strengths of 
implementing the project can become the driving forces that propel the project forward and 
promote a positive paradigm shift towards staff engagement in this educational quality 
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improvement initiative. One strength is that the agency has a strong culture of EBP knowledge 
and skillset, as well as stakeholders who are committed to implementing EBP in clinical practice 
to provide the best possible patient care. Therefore, the agency is invested in pursuing staff 
education regarding practices that will improve staff awareness of evidence-based depression 
management in patients with chronic pain. After assessing the strengths and weaknesses within 
the agency and of the tentative QI initiative, modifications can be made that will foster a smooth 
transition. For instance, if the agency has a strong EBP culture, but lack sufficient facilitators, the 
presenter can make arrangements to establish buy-in of key stakeholders prior to implementing 
the project. 
After the inhibiting forces have been rectified and the strengths have been promoted, the 
agency can cultivate a culture that will embrace the quality improvement initiative, which can be 
accomplished by engaging staff in EBP education regarding MBCT. One method that will serve 
to promote staff participation in the project is to highlight key benefits of MBCT specific to the 
agency’s patient population of individuals under palliative care. Once buy-in of the of the project 
is completed by stakeholders, increased participation of staff and providers should be observed 
(Melnyk & Fineout-Overholt, 2010). This writer postulates that the previous recommendations 
for the chosen project site will be instrumental for future practice but will not actually be enacted 
for this project. 
PICO Statement 
Given the scope of the area of interest for this proposed undertaking, the following study 
question was formulated: “In palliative care staff working with patients who have chronic pain, 
does educating team members about the of using MBCT for treating depression versus not 
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educating about the use of MBCT to treat depression, result in increased intent for palliative care 
staff to incorporate MBCT for treating depression among patients with chronic pain?” 
Methods for Finding Relevant Research 
The task of finding relevant literature pertaining to the use of MBCT for patients with 
chronic pain and depression was achieved through literature reviews in the CINAHL database 
utilizing specific search criteria. In the CINAHL database, the search terms “chronic pain” and 
“mindfulness” were selected, and the accompanying search was then limited to full text sources 
in English, generated in the last seven years by checking the appropriate fields on the left-hand 
side under the “refine results” tab with 135 articles then listed accordingly with six unique 
studies then selected. In a similar fashion, a search was conducted in the CINAHL database 
using search terms “mindfulness based cognitive therapy” and “depressive” limited to full text 
articles in English generated in the last seven years with 38 results of which four studies were 
then selected that met criteria for inclusion. Finally, the search terms “MBCT” and “depression” 
were used and in also limited to full text sources in English generated in the last seven years with 
51 results populated and two articles were selected accordingly. The selected articles consisted of 
the following types of studies: one systematic review, one meta-analysis, two systematic reviews 
with meta-analysis, five randomized controlled trials (RCTs), one quasi-experimental study, one 
qualitative grounded theory study and one quality improvement project (Appendix A). The 
rationale for inclusion was based upon the ability to apply knowledge gained from each study 
into the prospect for specifically addressing depression among patients with chronic pain. 
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Synthesis of Current Evidence in Literature 
After carefully analyzing the collective data, several key themes were derived regarding 
MBCT and the treatment of depression that collectively described study findings. The target 
audience in question for this quality improvement proposal primary revolves around patients in 
outpatient settings, and the vast majority of selected studies were also based upon outpatient 
populations to ensure appropriateness of findings for this project. The studies selected showed 
that most patients underwent MBCT training under the supervision of trained MBCT educators 
with sessions consisting of small groups of participants usually around 10 individuals. 
MBCT is well-tolerated and safe with no significant safety concerns identified during any 
of the studies included (Aalderen et al., 2012; Zgierska et al., 2016). Specifically, MBCT was 
identified as having excellent safety for both treatment of chronic pain and depression while 
demonstrating fewer side effects when compared to normal antidepressant pharmacological 
interventions (Huijbers, Spinhoven, Van Schaik, Nolen, & Speckens, 2016; Lilja, Zelleroth, 
Axberg, & Norlander, 2016; Mehl-Madrona, Mainguy, & Plummer, 2016). Furthermore, MBCT 
has the added benefit over traditional treatment as usual (TAU), using pharmacological 
antidepressant therapy, in the ability to teach participants positive, self-directed coping 
techniques that can be utilized to further bolster effectiveness for mitigating depressive 
symptoms, while also potentially limiting the risks for substance abuse and misuse (Barrett & 
Chang, 2016; Lestoquoy et al., 2017). Mindfulness-based therapies assist with directly lowering 
numerous depressive symptoms, negative perceptions related to pain and anxiety and help 
enhance overall pain control and quality of life (QOL) metrics (Hilton et al., 2017; Kuyken et al., 
2015; Lenz, Hall, & Smith, 2016; Lilja, Zelleroth, Axberg, & Norlander, 2016; Mehl-Madrona, 
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Mainguy, & Plummer, 2016; Mikolasek, Berg, Witt, & Barth, 2018; Shawyer, Enticott, Ozmen, 
Inder, & Meadows, 2016). MBCT when used in a complementary fashion to TAU has the added 
benefit of further controlling depressive symptoms and improving QOL while allowing 
individuals freedom of when and how to utilize mindfulness-based exercises that meets their 
unique lifestyles and choice of treatments (Aalderen et al., 2012; Hilton et al., 2017; Huijbers, 
Spinhoven, Van Schaik, Nolen, & Speckens, 2016; Mehl-Madrona, Mainguy, & Plummer, 
2016). While MBCT is promising as a potential treatment option for depressive symptoms, 
several of the studies involved a limited number of participants, with three of the 12 studies 
having less than 50 individuals, meaning that extrapolating data could be somewhat misleading 
given the relatively small sample sizes involved in these studies (Lestoquoy et al., 2017; Lilja, 
Zelleroth, Axberg, & Norlander, 2016; Zgierska et al., 2016). Furthermore, patients who undergo 
MBCT may have the additional advantage of fostering positive self-care skills that can prove 
significantly beneficial for patients with chronic pain who are at risk for abusing and misusing 
opioids. In summary, the available literature suggests that MBCT is generally safe, well-tolerated 
and effective at mitigating depressive symptoms, improving QOL indicators and enhancing pain 
control as an added benefit, when used either as a first line or adjunct therapy, without negative 
side effects commonly seen with traditional pharmacological antidepressant approaches.  
METHODS 
Design 
The structure selected for this project was a quality improvement design utilizing a 
pretest and posttest survey using a modified five-point Likert scale. The goal is to determine 
whether, following the educational session, there is an increase in palliative care team members’ 
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understanding of benefits and basic principles associated with utilization of MBCT in the 
treatment of depression, knowledge of benefits for reducing depressive episodes in patients 
diagnosed with chronic pain, awareness of tangible benefits that MBCT holds over traditional 
antidepressant therapies using medications, viability for using MBCT as an adjunct therapy for 
the treatment of depression and the provider’s comfort in actually recommending MBCT for 
patients with chronic pain and depression, in palliative care (Appendix B). This quality 
improvement initiative was non-randomized due to randomization not being feasible or 
beneficial for the focus of the project (Toulany, McQuillan, Thull-Freedman, & Margolis, 2013).  
Sample 
The specific team members offered the opportunity to participate in this project included 
Doctors of Medicine, nurse practitioners and Doctors of Osteopathic Medicine, registered nurses 
and social workers who specialize and currently work in palliative care practice.  
Description of the Educational Session 
Key areas highlighted during this presentation included the following points: a) the 
increased propensity of patients with chronic pain to have underlying depression, which has been 
shown to be exaggerated in patients who are on palliative care; b) significant risks for opioid 
abuse and misuse among patients diagnosed with chronic pain and depression; c) detriments 
associated with opioid abuse and misuse including risks for subsequent hospitalization, 
associated morbidity, mortality and higher healthcare costs; d) benefits of using MBCT for 
decreasing depressive symptoms, positive alteration in perceptions and acceptance of pain, 
improved QOL metrics and beneficial self-care coping skills and e) advantages of using MBCT 
both in terms of efficacy and limited side effects when compared to traditional pharmaceutical 
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antidepressants in the treatment of depression in adult populations (Aalderen et al. 2012; Barrett 
& Chang, 2016; CDC, 2017; Rajmohan & Kumar, 2013; Santarsieri & Schwartz, 2015). Upon 
completion of the education being given to staff, a posttest survey using the same five-point 
Likert scale questions was disseminated and the results analyzed to determine if staff knowledge 
and comfort level regarding recommending MBCT therapies had increased.  
Setting 
The site chosen for this project is a large hospice and palliative care organization that 
serves the greater Phoenix metropolitan areas. This location was specifically chosen as the focus 
centers around patients with advanced disease processes and goals of care are aligned with 
improving QOL. Approval from the site was obtained as required (Appendix C), as well as from 
the University of Arizona (Appendix D). Many of the patients under the care of this agency have 
underlying pathologies or undergo procedures that commonly manifest in chronic pain. 
Therefore, it is common to have patients who receive long-term opioid analgesic therapies while 
under palliative care. Given the high degree of chronic pain in conjunction with opioid 
prescribing, patients on service for palliative care at particularly high risk for depression and 
subsequent increased likelihood for opioid abuse and misuse (Grattan, Sullivan, Saunders, 
Campbell, & Von Korff, 2012; Rajmohan & Kumar, 2013).  
Resources 
Resources required include the materials to make and disseminate pretest and posttest 
surveys, which will be accomplished by using Qualtrics which is an online company that uses 
software as a service for creating, distributing and analyzing surveys that can be sent via email 
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addresses for the target audience. Additionally, the educational presentation which was created 
via PowerPoint was recorded through Panopto for easy viewing by participants (Appendix E). 
Data Collection and Analysis 
Following completion of the pretest survey, this writer provided an educational session, 
lasting approximately 30 minutes, that educated the staff about tangible benefits of utilizing 
MBCT in the treatment of depression in patients with chronic pain who are being treated under 
palliative care. In this way, the independent variable will be the educational webinar with the 
results of the pretest and posttest surveys serving as the dependent variables. Incomplete survey 
questions were omitted with only completed surveys sections being used as data points for this 
project. The survey answers corresponded with specific numerical values with strongly disagree 
representing the lowest score of ‘1’ and strongly agree having the highest numerical value of ‘5.’  
After the pertinent data from the surveys was collected, this writer transferred the values 
into the SPSS program to analyze data in addition to the Qualtrics data analysis tools. The data 
collected from the pretest and posttest surveys was then analyzed by performing a paired t-test to 
assess for changes in the mean values for each of the six questions that the staff members will 
answer. Paired t-tests are commonly used to compare mean values for two separate groups; for 
this project the two unique groups were identified as staff responses prior to receiving the 
educational information regarding MBCT for the treatment of depression and staff responses 
after being given the required educational information (Kim, 2015). Higher median values 
attained posttest represent a positive response to the intervention of the education material 
provided and higher scores can also be interpreted as a previous knowledge deficit regarding 
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palliative care staff member’s understanding, acceptance and willingness to utilize MBCT in the 
treatment of depression for patients under palliative care.  
Budget 
Resources required included the materials to make and disseminate pretest and posttest 
surveys and refreshments and food provided for the meeting with the overall budget required for 
this project being under $100.  
Ethical Considerations 
Ethical considerations for this project related to respect for persons, beneficence and 
justice. 
Respect for Persons  
Respect for persons involved in this project which entailed working in a collaborative and 
supportive role for educating healthcare workers who were the participants for this project tasked 
with providing care to the area of interest of this project, which focuses on palliative care 
patients with chronic pain and depression (Polit & Beck, 2017). 
Beneficence 
Beneficence involves providing the least amount of harm possible, balanced with the 
highest degree of benefit for all participants involved in research (Polit & Beck, 2017). Given 
that this project did not include direct patient research, there was no discernible risks for harm to 
participants. 
  
  
 
 
27 
Justice 
Justice was upheld by keeping all participants anonymous and allow for voluntary 
involvement in the project (Polit & Beck, 2017). This ensured fair treatment for all healthcare 
professionals who will engaged in this project.  
RESULTS 
Data Results and Interpretation  
Following the completion of the aforementioned pretest, educational presentation and 
posttest, the corresponding data was acquired and analyzed using both Qualtrics and SPSS 
software. Qualtrics analyzed data individually for the pretest and posttest. SPSS was utilized to 
ascertain the degree of change following the staff education undertaking using a paired T-test to 
analyze the differences between the pretest and posttest data (Appendix F). For the purpose of 
this project, the significance level was set for a p-value of 0.05, with values equal to or less than 
this metric showing evidence against the null hypothesis and thus supporting the merit of 
providing staff education regarding MBCT as it relates to patients with chronic pain who also 
suffer from depressive symptoms. There were a total of 25 participants for this project (N=25) 
who completed the surveys and educational undertaking, with all surveys that were not fully 
completed or missing the proper four-digit pin being omitted from the final results. 
The first question analyzed involved determining the staff member’s understanding of the 
basic concepts involved with using MBCT. Pretest scores showed a mean value of 3.00 on a 1 to 
5-point Likert scale with lower scores indicating a reduced understanding of for MBCT 
techniques and approaches to care and the corresponding posttest means value rising to 3.72 with 
a p-value of < .001 indicating a statistically significant improvement in survey scores following 
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the educational session being presented. The second survey question involved determining the 
staff member’s degree of faith in using MBCT as a means for treating depression. The pretest 
mean score for this category was found to be 3.48 which was then raised to 4.04 after the staff 
education was given which then correlated to a p-value of .001 which indicates a statistically 
significant improvement when compared to the pretest mean score. Next the third question in 
this project involved specifically inquiring about staff member’s belief that MBCT can actually 
reduce depressive symptoms. The mean value for the pretest score was found to be 3.64 with the 
posttest score then rising to 3.96 with the related p-value found to be .029 which also denotes a 
statistically significant improvement following the educational being provided to participants. 
The fourth survey question focused on each staff member’s comfort with using or considering 
the use of MBCT in treating depression. The average mean score for the pretest was found to be 
2.92 with the posttest value then increasing to 3.28 which translated into a p-value of .017 which 
also reflected a statistically significant improvement from pretest to posttest scores. Next the fifth 
survey question responses were analyzed which involved staff member’s comfort with 
recommending MBCT to their specific patient populations. The mean value for the pretest was 
determined to be 3.00 with the posttest value rising up to 3.60 which also had a related p-value of 
.001 that indicated a statistically significant value. Finally, the sixth and last question on the 
survey was evaluated which focused on staff member’s agreement that MBCT in an effective 
means for treating depressive symptoms when compared to more traditional antidepressant 
therapies. The mean value for the pretest was found to be 3.28 with the accompanying posttest 
mean value found to be 3.76 with a correlated p-value of .003 which again showed a statistically 
significant improvement between pretest and posttest scores. Collectively, the mean values of the 
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pretest and posttest data showed statistically significant improvement in all six different 
corresponding questions which supports the theory that palliative care staff members did indeed 
benefit from partaking in the education project that was presented by this writer.  
Analysis with Bonferroni Correction 
 To minimize the risk of inflated significance by using multiple t-tests, a Bonferroni 
correction was also applied, which reduced the required p-value for significance. This step 
minimizes the risk for type 1 errors when analyzing multiple comparisons that are based upon 
one set of data collected. The revised p-value of <.01 still rendered significant differences in the 
comparison of pretest and posttest results on 4 of the 6 survey items, with questions 3 and 4 very 
close to significance, at .029 and .017, respectively. 
Conclusion 
Despite a myriad of advancements in modern healthcare practices, depression remains a 
serious concern that is worthy of discussion while alternative and adjunct methods that can help 
to address depressive symptoms amongst sufferers are scrutinized. As discussed in detail within 
this paper, depressive symptoms are more often manifested in individuals who also suffer from 
chronic pain, and palliative care patient populations are a unique and highly vulnerable 
population to suffering from both chronic pain and depression. Depression is also a key risk 
factor for patients engaging in unsafe medical practices of self-medicating, which includes the 
misuse and abuse of prescribed opioids which are commonly prescribed to patients with chronic 
pain under palliative care. Additionally, despite the benefits from using antidepressant therapies, 
this category of medications also come with a unique set of side effects that can negatively affect 
a patient’s quality of life despite treating the underlying depressive symptoms. MBCT is an 
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evidenced-based approach specifically designed to treat depression and prevent depressive 
relapses while also improving the participant’s overall mindfulness and assisting them with 
developing healthy coping techniques to deal with their depression. Furthermore, literature 
informs that MBCT is generally safe and can be used a primary or adjunct therapy for treating 
patients with depression while also not having the unwanted side effects often seen with 
traditional antidepressant therapies. This project illustrated how education regarding the use of 
MBCT can be beneficial for palliative care staff members to improve their understanding and 
acceptance of MBCT practices. In turn, this may serve to increase staff knowledge and may 
further promote the use of MBCT as a viable means for addressing depression for patients with 
chronic pain who are cared for under palliative care. 
DISCUSSION 
Overview 
 From the onset of this project, this writer theorized that the staff education provided 
would serve as a means for enlightening palliative care staff members which would then translate 
into higher posttest survey scores. When reviewing the statistical data extrapolated for this 
project, it is important to note that all p-values for the accompanying six questions included in 
the pretest and posttest surveys showed statistically significant improvements. Additionally, even 
with a Bonferroni correction, four out of the six survey responses still showed statistically 
significant changes from pretest mean scores compared to posttest mean scores, further 
substantiating the stance that the educational intervention was indeed effective at improving staff 
members’ knowledge of MBCT as it pertains to treating depression. The first question in the 
project involved rating the participant’s understanding of key concepts involved in the use of 
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MBCT as it relates to treating depression. The baseline mean scores from pretest rose from 3.00 
to 3.72 with an accompanying p-value of < .001 which indicates that participants did indeed 
show improvements in their understanding of MBCT following the educational presentation. 
This could indicate a lack of participant’s knowledge regarding the use of MBCT for treating 
depression prior to attending the presentation, which was then enhanced through the educational 
participants received. The second question involved gauging the participants level of 
understanding regarding the benefits of MBCT in the treatment of depression. The pretest mean 
score for this category was found to be 3.48 which was then rose to 4.04 after the staff education 
was given which then correlated to a p-value of .001 which indicates a statistically significant 
improvement in the participants’ belief in viewing MBCT as a viable means for treating 
depression. Next, the third question in this project involved specifically inquiring about staff 
members’ belief that MBCT can actually reduce depressive symptoms. The mean value for the 
pretest score was found to be 3.64 with the posttest score then rising to 3.96 with the related p-
value found to be .029 which also denotes a statistically significant improvement following the 
educational being provided to participants. These findings support the stance that staff members’ 
faith in MBCT as a viable means for reducing depressive symptoms was improved upon as a 
result of the educational session. The fourth survey question centered on participants’ comfort 
with using or considering the use of MBCT in treating depression. The average mean score for 
the pretest was found to be 2.92 with the posttest value then increasing to 3.28 which translated 
into a p-value of .017 which reflected a statistically significant improvement in staff members’ 
comfort and consideration for using MBCT to treat depression. These findings could support the 
stance that participants who received the supplemental education regarding MBCT felt more 
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comfortable in actually considering the use of MBCT as a viable treatment option for patients 
with depression. The fifth survey question responses were analyzed which involved staff 
members’ comfort with recommending MBCT to their specific patient populations. The mean 
value for the pretest was determined to be 3.00 with the posttest value rising up to 3.60 which 
also had a related p-value of .001 that indicated a statistically significant value and supports the 
hypothesis that staff members’ comfort with recommending MBCT strongly improved following 
the educational session. Finally, the sixth and last question on the survey was evaluated and this 
focused on staff member’s agreement that MBCT is an effective means for treating depressive 
symptoms when compared to more traditional antidepressant therapies. The mean value for the 
pretest was found to be 3.28 with the accompanying posttest mean value increasing to 3.76 with 
a correlated p-value of .003 which again showed a statistically significant improvement between 
pretest and posttest scores supporting a positive outcome on staff members’ belief in the 
effectiveness of MBCT when compared to traditional antidepressant therapies following staff 
receiving the previously mentioned education. Collectively, the mean values of the pretest and 
posttest data showed statistically significant improvement in all six different corresponding 
questions which supports the theory that palliative care staff members did indeed benefit from 
partaking in the education project that was presented by this writer.  
Relevance to Frameworks, Aims and Current Literature 
 With regards to the previously discussed theoretical frameworks, the initial steps in 
Lewin’s change theory and Melnyk’s ARCC model, both of which involve acknowledging a 
specific problem exists, was accomplished by collaborating with the site’s Medical Director and 
the agency’s leadership team who did acknowledge a lack of knowledge regarding the use of 
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MBCT in treating depression, and this correspondence was made prior to this project being 
implemented. The second step in the Lewin’s change theory involves changing current processes 
and demonstrating how other practices may have beneficial outcomes. This was partially 
accomplished by through the educational intervention with results indicating a positive outcome 
for participants who took part in the educational undertaking. This step could further be 
solidified should the agency actually use this quality improvement endeavor to change clinical 
practice. Furthermore, the aim of the project which involved improving palliative care staffs’ 
knowledge regarding the use of MBCT for treating depression in palliative care patients who 
have chronic pain was met and the results of this project indicates that the education intervention 
was effective for enhancing participant’s knowledge and acceptance of MBCT. Additionally, this 
writer did also peruse current literature for the purpose of comparing this project with other 
current evidence. This literature review showed that this project was unique with regard to the 
design and study question. In no other article found by this author did researchers aim to educate 
palliative care staff specifically regarding using MBCT for their patients who have depression 
and chronic pain. Therefore, this project did provide unique data that serves to inform the 
research community that valuable data could be gained through further exploration into this 
particular topic which would positively impact clinical practice, despite the fact that this project 
endeavor was not research-based in nature. 
Strengths and Limitations of the Project 
 After reviewing the data collected, the first strength of the project becomes evident and 
this lies in the data which shows statistically significant improvements for all six questions, 
which demonstrates a positive outcome of the educational intervention as it pertains to the staff 
  
 
 
34 
members’ improvement in knowledge regarding MBCT for treating depression. Additionally, the 
expected and observed outcomes for this project matched the previously hypothesized stance that 
palliative care staff would indeed benefit from the educational presentation, which was 
illustrated in the statistically significant improvement between pretest and posttest surveys. 
Furthermore, once the results were subjected to a Bonferroni correction, four out of the six 
survey items still showed statistically significant results, with survey items three and four still 
very close to significant values, which was also deemed a strength for this project. The final 
strength identified from this project was in the number of participants who completed both 
surveys and attended the education session. While 25 participants may be regarded as a relatively 
small sample size, this number represent about one-third of the entire agency’s clinical staff 
which could also be argued as a strength. 
 Despite the outlined strengths, there are limitations of this project that are also worthy of 
discussion. This includes the lack of acquiring additional participant data, including age, gender 
and specific job roles, which could have been used to further analyze the data collected and 
determine unique variables that may have been evident. Furthermore, there was a relatively small 
sample size and, while purposefully done, all participants were from one palliative care setting, 
which decreases generalization of the results. However, the results were encouraging as the 
palliative care staff members appeared to gain knowledge and insight with regards to MBCT as it 
pertains to treating depression in patients with chronic pain and this was evidenced by the higher 
corresponding posttest scores. 
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Implications for Current and Future Practice 
 Given the improved metrics for all corresponding posttest results, this project could serve 
as a platform for the agency involved to conduct further research projects regarding MBCT for 
treating depression, or even potentially serve as a catalyst to promote positive changes to current 
guidelines and practices. This writer provided an executive summary of this project’s findings 
and disseminated this information to the agency’s Special Projects Coordinator. Additionally, 
several members of the leadership team who attended the meeting voiced their interest in further 
looking at possibly incorporating MBCT into current and future practice and stated their intent to 
look into options in the near future. Furthermore, the Special Projects Coordinator asked this 
writer for permission to use this material for potentially teaching and educating new staff 
regarding the use of MBCT for addressing depression among patients with chronic pain under 
palliative care services. This step could further serve to modify clinical practice if the agency 
uses the information gained from this project to change their clinical practice to include MBCT 
for addressing patients’ depression, however, this would involve a separate quality improvement 
initiative outside of the scope for this specific project. Finally, this project could also be used as a 
catalyst for future research endeavors as the results of the data show a positive correlation 
between MBCT education and its effects on staff perceptions and beliefs regarding MBCT in 
treating depression.      
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APPENDIX A: 
SYNTHESIS OF EVIDENCE 
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PICO Statement: “In palliative care staff working with patients who have chronic pain, does educating team members about the of using MBCT for 
treating depression versus not educating about the use of MBCT to treat depression, result in increased desire for palliative care staff to incorporate 
MBCT for treating depression among patients with chronic pain?” 
Author/ 
Article 
Qual: 
Concepts or phenomena 
Quant: Key variables 
Hypothesis and research 
question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Aalderen,, Donders, 
A., Giommi, F., 
Spinhoven, P., 
Barendregt, H. & 
Speckens, A. 
 
The eﬃcacy of 
mindfulness-based 
cognitive therapy in 
recurrent depressed 
patients with and 
without a current 
depressive episode: 
a randomized 
controlled trial.  
A quantitative study to 
determine the 
effectiveness of using 
MBCT in conjunction 
with TAU for individuals 
with and without recurrent 
depression. 
Not listed Randomized 
controlled 
trial.  
The total 
number of 
participants 
involved was 
N = 205 with 
102 involved 
in the 
experimental 
group and 
103 in the 
control 
group.  
This study used the 
HAMD, BDI, the 
Rumination of Sadness 
Scale (RSS), the Penn 
State Worry 
Questionnaire (PSWQ), 
the Kentucky Inventory 
of Mindfulness (KIMS) 
and the World Health 
Organization Quality of 
Life Questionnaire 
(WHOQOL) tools to 
measure depressive 
symptoms and QOL 
indicators. 
 
Patients who underwent 
MBCT in conjunction 
with TAU showed less 
depressive symptoms, 
worry and rumination 
and improved positive 
self-coping when 
compared to the TAU 
group. This study 
concluded that MBCT 
was safe as a treatment 
option for patients with 
and without recurrent 
depression when used 
with TAU.  
Barrett, K, & Chang, 
Y. 
 
Behavioral 
interventions 
targeting chronic 
pain, depression, and 
substance use 
disorder in primary 
care. 
Quantitative review that 
sought to compare the 
effectiveness of 
Mindfulness Oriented 
Recovery Enhancement 
(MORE), Acceptance and 
Commitment Therapy 
(ACT), Interpersonal 
Psychotherapy adapted for 
pain (ITP-P) and CBT for 
addressing chronic pain 
Not listed Systematic 
review 
Six unique 
RCTs were 
included for 
this review 
with a total 
sample size 
of 696 
individuals.  
The Preferred 
Reporting Items for 
Systematic Reviews 
and Meta-Analyses 
(PRISM) guidelines 
were used to direct this 
review.  
Mindfulness-based 
interventions showed 
significant positive 
effects in terms of 
managing chronic pain, 
substance abuse and 
underlying depression 
for patients treated in the 
primary care setting 
while enhancing positive 
self-coping skills.  
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Author/ 
Article 
Qual: 
Concepts or phenomena 
Quant: Key variables 
Hypothesis and research 
question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
 depression and substance 
abuse in the primary care 
setting.  
 
     
Hilton, L., Hempel, 
S., Ewing, B., 
Apaydin, E., 
Xenakis, L., 
Newberry, S., 
Colaiaco, B., Maher, 
A., Shanman, R., 
Sorbero, M. & 
Maglione, M. 
 
Mindfulness 
meditation for 
chronic pain: 
systematic review 
and meta-analysis.  
 
Quantitative study that 
examined the effectiveness 
of MBCT and MBSR 
therapies in improving 
chronic pain, depression, 
QOL and impairment and 
disability.  
Not listed Systematic 
review and 
meta-
analysis.  
The review 
encompassed 
38 unique 
RCTs that 
involved 
3,536 total of 
participants. 
Chronic pain was 
measured using the 
McGill Pain 
Questionnaire and the 
SF-36 scales, 
depression scores were 
measured using the 
Beck Depression 
Inventory and Patient 
Health Questionnaire, 
physical and mental 
(QOL) measured using 
the SF-36 scale and 
finally, functional 
impairment and 
disability was measured 
using the Roland-
Morris Disability 
Questionnaire and the 
Sheehan Disability 
Scale. 
 
Collectively, 
mindfulness therapies 
were effective at 
improving pain, 
depression and QOL 
metrics, however, it was 
noted that additional 
well-designed RCTs 
were needed to fully 
substantiate the benefits 
of mindfulness therapies 
for addressing chronic 
pain.  
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Huijibers, M., 
Spinhoven, P., 
Schaik, D., Nolen, 
W. & Speckens, A. 
 
Patients with a 
preference for 
medication do 
equally well in 
mindfulness-based 
cognitive therapy 
for recurrent 
depression as those 
preferring 
mindfulness. 
Quantitative study 
that involved 2 
parallel RCTs. 
This study sought 
to determine if 
patient preference 
for maintenance 
antidepressant 
medication 
(mADM) or 
MBCT would 
affect treatment 
adherence and 
effectiveness of 
interventions in 
preventing 
depressive 
relapses.  
 
Not listed.  Two parallel 
RCTs. The 
first RCT 
compared 
MBCT to 
MBCT and 
mADM in 
patients who 
preferred 
mADM. The 
second RCT 
involved 
mADM to 
MBCT and 
mADM in 
patients who 
preferred 
mADM.  
 
The first RCT 
included 249 
participants and the 
second RCT had 68 
for a total sample 
size of 317 
individuals.  
Treatment preference 
was measured using the 
Treatment Credibility 
Questionnaire (TCQ). 
Depressive relapse was 
measured using the 
Structured Clinical 
Interview while 
depressive symptoms 
and QOL were 
measured with the 
Inventory of Depressive 
Symptomology tool.  
Adherence to 
MBCT treatment 
was not changed 
based upon 
treatment 
preference and no 
significant 
differences in rates 
of depressive 
relapse, severity of 
symptoms or 
effects on QOL 
were noted 
between the two 
preference groups.  
Kuyken, W., 
Hayes, R., Barrett, 
B., Byng, R., 
Dalgleish, T., 
Kessler, D., Lewis, 
G., Watkins, E., 
Brejcha, C., Cardy, 
J., Causley, A., 
Cowderoy, S., 
Evans, A., 
Gradinger, F.,  
Quantitative 
analysis. Research 
question: Is MBCT 
with intent to taper 
to discontinue 
antidepressant 
therapy more 
effective at 
preventing relapses 
in depressive 
episodes versus  
None Listed. Single-blind 
parallel 
randomized 
controlled 
trial. 
212 patients were 
assigned to the 
experimental group 
involving MBCT 
and 212 were the 
control group 
utilizing TAU in the 
form of continued 
antidepressant 
therapy, with 
N=424.  
Relapse in depression 
was measured using the 
Structured Clinical 
Interview from the 
DSM-IV (SCID) tool as 
the primary outcome 
that was measured. 
Residual depressive 
manifestations were 
measured using the 
GRID-Hamilton Rating  
While not superior 
to TAU with 
antidepressant 
therapy, MBCT 
was similar in 
terms of preventing 
relapses in 
depression, 
reducing 
depressive 
symptoms and  
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Kaur, S., Lanham, 
P., Morant, N., 
Richards, J., Shah, 
P., Sutton, H., 
Vicary, R., 
Weaver, A., Wilks, 
J.,Williams, M., 
Taylor, R. & 
Byford, S.  
 
Effectiveness and 
cost-effectiveness 
of mindfulness-
based cognitive 
therapy compared 
with maintenance 
antidepressant 
treatment in the 
prevention of 
depressive relapse 
or recurrence 
(PREVENT): A 
randomized 
controlled trial. 
 
TAU with 
antidepressant 
therapy? 
   Scale for Depression 
(HAMD) and the 21-
item Beck Depression 
Inventory (BDI), while 
QOL was measured 
using the WHO Quality 
of Life Instrument. 
improving QOL 
scores. 
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Lenz, A. & Hall, J. 
 
Meta-analysis of 
group mindfulness-
based cognitive 
therapy for 
decreasing 
symptoms of acute 
depression. 
Quantitative study 
with three specific 
research questions 
were asked: 1) 
How effective is 
MBCT in 
addressing 
depressive 
symptoms versus 
no treatment or 
alternative 
treatments? 2) 
How do study 
designs and 
participant traits 
impact effects of 
MBCT? and 3) 
How effective is 
MBCT when 
scrutinized at 
specific follow-up 
intervals? 
 
Not listed  Meta-
analysis.  
31 unique studies 
were selected for 
inclusion with a 
total sample size of 
2,352 individuals. 
Mean differences in 
variance was 
determined using the 
Hedge’s g tool. To 
analyze homogeneity, 
the Cochran’s Q tool 
was utilized. Predictive 
relationships including 
age, gender and Country 
was computed by the 
Knapp and Hartung 
procedure. 
MBCT was 
demonstrated to be 
superior at 
managing 
depressive 
symptoms when 
compared to no 
treatment or 
alternative 
treatments. No 
significant 
differences 
between age or sex 
were noted with 
studies included in 
this meta-analysis 
with minimal 
homogeneity 
attributed to 
country of origin 
and type of 
treatment in which 
MBCT therapy 
was compared to. 
MBCT effects 
were also found to 
potentially enhance 
over time.  
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Lestoquoy, A., 
Laird, L., Mitchell, 
S., Gergen-Barnett, 
Negash, N., 
McCue, K., Enad, 
R. & Gardiner, P.  
 
Living with 
chronic pain: 
Evaluating patient 
experiences with a 
medical group visit 
focused on 
mindfulness and 
non-tautological 
strategies. 
Qualitative study 
that sought to 
answer the 
following 
question: How will 
patients with 
chronic pain and 
depression who are 
of racially diverse 
and low-income 
backgrounds react 
to mindfulness 
therapies and what 
will their 
experiences yield?  
Modified 
grounded theory. 
Using the 
modified 
grounded 
theory, 
specific 
themes were 
identified 
based upon 
the 
participant’s 
experience 
following 
group 
sessions.  
20 total participants 
from low-economic 
status with diverse 
racial backgrounds.  
To qualify for the study, 
participants had to have 
numeric pain scores of 4 
or greater out of 10 and 
depression of 5 or 
greater out of 10 on the 
Patient Health 
Questionnaire with all 
transcripts of the focus 
group coded using the 
NVivo 10 software.  
Six unique themes 
were identified: 1) 
Living with 
chronic pain was 
isolating, 2) group 
therapy enhanced 
ability to cope with 
pain, 3) pain 
exacerbations were 
unpredictable and 
dependence on 
medication and 
follow-up 
appointments 
resulted in feelings 
of lack of 
autonomy and 
control, 4) group 
therapies improve 
control over 
individuals’ health, 
5) navigating the 
healthcare system 
and treatment 
options are often 
unsatisfying and 6) 
non-medication 
therapies taught led 
to new coping 
techniques.  
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Lilja, J., Zelleroth, 
C., Axberg, U. & 
Norlander, T. 
 
Mindfulness-based 
cognitive therapy 
is effective as 
relapse prevention 
for patients with 
recurrent 
depression in 
Scandinavian 
primary health 
care. 
Quantitative study 
that examined the 
following 
questions: 1) Can 
MBCT be used to 
prevent depression 
in primary care? 2) 
Are their gender-
specific 
differences in 
outcomes? 3) Does 
motivation and 
therapeutic 
association affect 
outcomes? 4) What 
are the statistically 
significant 
differences in 
terms of 
outcomes?  
Not listed. Quasi-
experimental 
pre and 
posttest 
comparing 
MBCT 
treatment 
group with 
TAU group in 
patients 
diagnosed 
with recurrent 
depression.  
This study used a 
total sample size of 
N = 45.  
The Five Facets of 
Mindfulness 
Questionnaire (FFMQ), 
the Hospital Anxiety 
and Depression Scale 
(HADS), the Life 
Satisfaction 
Questionnaire (LSQ), 
Working Alliance 
Inventory, Nijmegen 
Motivation List for 
Prevention (NML2) and 
the Primary Care 
Evaluation of Mental 
Disorders (Prime-MD) 
were used to measure 
depression, anxiety and 
QOL both pre and 
posttest.  
 
Two-thirds of 
participants 
showed 
improvements in 
depression and 
anxiety with a 
decreased relapse 
rate for patients 
who underwent 
MBCT.  
Mehl-Madrona, L., 
Mainguy, B. & 
Plummer, J. 
 
Integration of 
complementary 
and alternative 
medicine therapies 
into primary-care 
pain management  
Quantitative study 
that sought to 
answer whether 
complementary 
and alternative 
medicine (CAM) 
approaches (that 
included 
mindfulness 
interventions)  
Not listed. Quality 
improvement 
project. 
207 patients were 
enrolled in the 
experimental group 
who received CAM 
therapies and 207 
patients received 
TAU for the control 
with N=414. 
A numeric pain scale 
rating between 0-10 was 
used to measure pain 
levels, while the My 
Medical Outcome 
Profile 2nd version was 
used to measure QOL 
scores. 
Statistically 
significant 
improvements in 
pain and QOL 
scores were noted 
in patients who 
underwent CAM 
therapies that 
included 
mindfulness  
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
for opiate 
reduction in a rural 
setting. 
 
could assist with 
reducing pain 
intensity and 
dependence on 
opioid analgesics 
while improving 
QOL metrics. 
 
    exercises. 
Additionally, 17 
patients reduced 
their opioid doses 
and seven patients 
completed stopped 
requiring opioid 
therapy altogether.  
 
Mikolasek, M., 
Berg, J., Witt, C. & 
Barth, J. 
 
Effectiveness of 
mindfulness 
relaxation-based 
eHealth 
interventions for 
patients with 
medical 
conditions: A 
systematic review 
and synthesis. 
Quantitative 
analysis to review 
studies that utilized 
either mindfulness-
based stress 
reduction (MBSR) 
therapies or MBCT 
therapies. The 
research question 
was, “Do eHealth 
MBSR and MBCT 
approaches 
improve a patient’s 
physical and 
psychological 
health?”  
None listed.  Systematic 
review with 
synthesis. 
This review 
encompassed 17 
unique articles with 
a collective sample 
size of 1,855 
patients.  
Inclusion criteria 
included pre and 
posttest results for 
physical or 
psychological outcomes. 
Studies were between 
1990 to 2015 collected 
from five different 
databases. To validate 
external validity, the 
Downs and Black 
checklist was utilized.  
Out of the 17 
unique studies 
included, four 
studies focused 
specifically on 
depression with 
patients who 
underwent eHealth 
mindfulness 
therapy showing 
superior control of 
depressive 
symptoms in one 
study and equal 
efficacy when 
compared to TAU 
in the other three 
studies.  
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Author/ 
Article 
Qual: 
Concepts or 
phenomena 
Quant: Key 
variables 
Hypothesis and 
research question 
Theoretical 
Framework 
Design Sample (N) Data Collection 
(Instruments/ 
Tools) 
Findings 
Shawyer, F., Enticott, J., 
Ozmen, M., Inder, B. & 
Meadows, G. 
 
Mindfulness-based 
cognitive therapy for 
recurrent major 
depression: A ‘best buy’ 
for health care? 
Quantitative 
research with a 
research question 
of “How beneficial 
and cost effective 
is MBCT for 
reducing 
depressive relapses 
in patients with a 
history of recurrent 
major depressive 
episodes (MDEs)” 
None listed.  Randomized-
controlled trial 
consisting of 
experimental 
group who 
underwent 
MBCT plus 
depressive 
relapse 
monitoring and 
a control group 
who only had 
depressive 
relapse 
monitoring.  
The 
experimental 
group 
consisted of 
101 patients 
and a control 
group of 102 
patients with 
203 total 
participants. 
The Depression Awareness 
and Study design was used 
with depression relapse 
and monitoring (DRAM) 
tool to measure total 
MDEs over the course of 
26 months. To estimate 
clinical delivery costs, the 
Medicare Benefit Schedule 
(MBS) was utilized.  
 
Patients who 
underwent MBCT 
consistently showed 
lower MDEs when 
compared with the 
control group. Also, 
the clear majority of 
9 subgroups showed 
cost-savings for 
those who 
underwent MBCT 
with the exception 
of just one group.  
Zgierska, E., Burzinski, 
C., Cox, J., Kloke, J., 
Stegner, A., Cook, D., 
Singles, J., Mirgain, S., 
Coe, C. & Bačkonja, M. 
 
Mindfulness meditation 
and cognitive behavioral 
therapy intervention 
reduces pain severity and 
sensitivity in opioid-
treated chronic low back 
pain: Pilot findings from a 
randomized controlled 
trial. 
Quantitative study 
that looked at the 
MBCT as it relates 
to mitigating 
chronic lower back 
pain (CLBP), 
disability and 
dysfunction, 
thermal pain 
perception, pain 
acceptance and 
opioid usage.  
Not listed Randomized 
controlled trial. 
21 
participants 
were enrolled 
into the 
experimental 
group with 14 
placed in the 
control group 
with N=35.  
Pain scoring was done 
using a numeric pain scale 
rating between 0-10, 
disability was measured 
using the Oswestry 
Disability Index, a 
Thermal Sensory Analyzer 
was used to measure 
thermal pain perceptions, 
the 20-Item Chronic Pain 
Acceptance Questionnaire 
and self-reported opioid 
usage (both by prescription 
and by illicit use).  
MBCT showed 
statistically 
significant 
improvements in 
pain severity and 
thermal pain 
perception. 
Additionally, MBCT 
was determined to 
be safe when used in 
an adjunct fashion to 
long-term opioid 
therapy in patients 
with CLBP.  
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MINDFULNESS-BASED COGNITIVE THERAPY QUESTIONNAIRE 
To what degree do you agree with the 
following statements? 
Strongly 
Disagree 
(1) 
Disagree 
(2) 
Neither Agree 
nor Disagree 
(3) 
Agree 
(4) 
Strongly 
Agree 
(5) 
I understand key concepts of mindfulness-
based cognitive therapy (MBCT). 
     
I recognize the benefits of using MBCT in 
the treatment of depression. 
     
I believe MBCT can help reduce 
depressive episodes. 
     
My current practice uses or considers 
using MBCT for addressing depression. 
     
I feel comfortable in recommending 
treatments like MBCT. 
     
I believe MBCT is effective when 
compared to traditional antidepressant 
therapies.  
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